ReviewAnnals of hematology2014

Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.

Antonino Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.